Solid Cultivated Antrodia Cinnamomea Mycelia
Greenyn Antrodia cinnamomea mycelia is the first USFDA recognized A. cinnamomeda product
In-vitro test: inhibit hepatitis B virus
Animal test: enhance liver metabolism, reduce liver damage
Human clinical trials: reduce the amount of virus and significantly improve liver function in patients
Cell test- Anti HBV activity Anti cancer cell test
Animal test- Hangover relieving test Blood triglyceride test Alcohol-induced liver injury
Clinical experiment-Clinical trials of Antromax on patients with chronic hepatitis B Subjects: 14 people (Antromax+ Placebo)/ 15 People (Antromax+Entecavir) Group A: Antromax+ Placebo Antromax 1500mg/day + Placebo 0.5mg/day Group B: Antromax + Drug Antromax 1500mg/day + Entecavir 0.5mg/day
Antromax
Ruby of the Forest in Taiwan
Please contact us with any questions